u/Embarrassed-Tea-517

▲ 7 r/ScientificNutrition+1 crossposts

Single-Dose Creatine Reduces Sleep Deprivation-Induced Deterioration in Cognitive Performance

Creatine is often marketed toward gym bros, but its other benefits are underrated, especially its positive effects on cognitive function and sleep.

This recent 2026 study shows that creatine, even at a lower dose of 0.2 g/kg, helps to reduce the decline in cognitive performance caused by sleep deprivation. The study found that creatine mitigated deterioration in logical and numerical tasks, language-related processing speed, and Psychomotor Vigilance Test (PVT) performance. While the effect was less pronounced than with a higher dose (0.35 g/kg) used in a previous study, there was still an improvement of up to 12%. Notably, females benefited more than males in tasks involving logic, PVT, and processing speed in language and logic. These findings suggest that both the cellular stress from sleep deprivation and sufficient creatine availability are crucial for the observed cognitive benefits.

mdpi.com
u/Embarrassed-Tea-517 — 3 days ago
▲ 15 r/ScientificNutrition+2 crossposts

A recently published 2026 study found that a probiotic yogurt containing L. paragasseri OLL2716 improved sleep length and reduced stress hormones in medical students during exam season.

78 Japanese 4th-year medical students ate 85g of yogurt daily for 8 weeks containing Lactobacillus paragasseri OLL2716 (or placebo). Two real academic exams served as stress events.

What they found:

  • The probiotic group woke up feeling less groggy at 2 and 4 weeks
  • They slept objectively longer at 2, 4, and 7 weeks
  • Stress hormone markers were significantly lower: chromogranin A at week 4, cortisol at week 5
  • Anxiety levels didn't differ between groups, but sleep and stress hormones did, suggesting the probiotic may be working on the physiological stress-response pathway rather than just mood perception. That's a gut-brain axis angle worth paying attention to.

Study Limitations:

  • Small sample (78 people)
  • Fitbit sleep tracking isn't clinical-grade polysomnography
  • Conflict of interest: study funded by the Japanese dairy company that makes this exact yogurt and 5 of the study's authors are full-time employees of that company.The study design itself is solid (randomized, double-blind, placebo-controlled), but independent replication is needed before drawing firm conclusions.

Study link: https://www.journalofdairyscience.org/article/S0022-0302(26)00099-8/fulltext

u/Embarrassed-Tea-517 — 10 days ago

Vitamin C is well known for supporting the immune system and helping regulate blood pressure, but a new study suggests it may also help slow the aging process itself.

Researchers discovered a newly named aging process called "ferro-aging": as we age, iron builds up in our cells, damaging cell membranes and pushing cells into a dysfunctional "zombie" state that accelerates aging body-wide. A key enzyme called ACSL4 drives this process, and older people have significantly more of it than younger people.

After screening 100 molecules, they found Vitamin C most effectively blocks ACSL4. They then gave aged monkeys Vitamin C daily for 40 months. Results showed that Vitamin C reduced oxidative stress, inflammation, and cellular senescence across multiple organs, and reversed biological age as measured by aging clocks. Brain scans showed less shrinkage, and metabolic health improved - lower bad cholesterol, less belly fat, and better blood sugar control.

The catch: The monkeys received very high doses (~2,100 mg/day for a 70 kg human), far above standard recommendations, and this hasn't been tested in humans yet.

Study Link: https://www.sciencedirect.com/science/article/pii/S1550413126000537?via%3Dihub

u/Embarrassed-Tea-517 — 22 days ago

I went down a rabbit hole after reading a 2019 paper and the implications kept stacking. Sharing for discussion because I think this is one of the most underappreciated findings in dementia research.

In the 2019 study, Porphyromonas gingivalis, the key pathogen in chronic periodontitis (gum disease), was detected in the post-mortem brains of Alzheimer's patients. Its toxic enzymes, called gingipains, were also found there, and their levels correlated strongly with tau pathology and ubiquitin pathology, two of the definitive hallmarks of Alzheimer's disease. This isn't correlationtho - the paper demonstrates a mechanistic pathway: oral P. gingivalis → brain colonization → gingipain neurotoxicity → tau fragmentation → neurodegeneration. It doesn't prove P. gingivalis causes Alzheimer's in humans definitively, but the convergent evidence is striking.

A 12-year study tracked 1,221 married couples aged 65+. People whose spouses developed dementia were six times more likely to develop dementia themselves compared to those whose spouses did not. This risk was comparable in magnitude to carrying the APOE ε4 gene variant. It held up after adjusting for socioeconomic status and other confounders. The researchers at the time attributed this primarily to caregiver stress. That's plausible. But it's probably not the whole story.

If P. gingivalis is part of that exchanged microbiome, and if it can colonize the brain and drive the pathological cascades Dominy et al. describe, then couples who have lived together for decades may genuinely share a shared neurological risk via a microbial route - on top of whatever stress or lifestyle factors they also share.

A 2025 study directly investigated this idea, finding that gut microbiota dysbiosis associated with Alzheimer's could be transmitted between individuals and contribute to cognitive pathogenesis in both mouse models and patient data.

If there is even a partial microbial mechanism here, then treating periodontitis aggressively in both partners becomes a potentially meaningful dementia risk-reduction strategy. Not a cure. Not a guarantee. But a lever we already have.

None of this proves Alzheimer's is "contagious" in any conventional sense. The Dominy et al. paper also carries a conflict of interest — most authors were affiliated with Cortexyme Inc., which was developing gingipain inhibitors as a commercial drug. The field has not reached consensus. What it does suggest is that oral health may be a modifiable risk factor worth taking far more seriously than it currently is in dementia prevention guidelines.

u/Embarrassed-Tea-517 — 24 days ago